Pseudotumor Cerebri

Pseudotumor cerebri means the pressure inside the skull is higher than normal even though there is no brain tumor. The word “pseudo” means “false,” so the name says it acts like a tumor but there is not a tumor. Doctors also call it idiopathic intracranial hypertension, which means “high pressure in the head with no clear cause.” The condition can cause headache, ringing sound in the ears, and swelling of the optic nerve called papilledema. The swelling can lead to vision loss if it is not recognized and treated in time. The diagnosis requires normal brain imaging, normal spinal fluid chemistry, and a high opening pressure when spinal fluid is measured. In adults, an opening pressure of 25 cm of water or more supports the diagnosis when the rest of the evaluation is otherwise normal. In children, the threshold is 28 cm if they are obese or sedated. These cutoffs come from standard diagnostic criteria used by neurologists and eye specialists. American Academy of NeurologyJNNPPMC

Pseudotumor cerebri means the pressure inside your head (intracranial pressure) is too high even though brain scans don’t show a tumor or another space-taking problem. The pressure builds up in the fluid that bathes the brain and optic nerves (cerebrospinal fluid, or CSF). This pressure can cause daily headache, whooshing tinnitus in the ears (a pulse-like sound), blurred vision, short blackouts of vision, and swollen optic nerves (papilledema) that can damage sight if not treated quickly. Doctors diagnose IIH when symptoms and eye findings fit, brain imaging rules out other causes, and a lumbar puncture confirms high opening pressure with otherwise normal fluid studies. The core goals are simple: lower the pressure, protect vision, and reduce headache disability. PMC

Doctors first make sure the optic nerve swelling is real and not something that only looks like swelling. They then do brain imaging to rule out other causes of pressure such as a venous clot. Only after imaging is done do they perform a lumbar puncture to measure the opening pressure and to check that the spinal fluid contents are normal. This stepwise approach is used because doing a lumbar puncture before imaging could be unsafe if a mass were present, and because the number alone should not be used without the rest of the clinical picture. American Academy of OphthalmologyJNNP

Types

1) Primary (Idiopathic) IIH. This is the classic form where no single cause is found. It is most common in women of child-bearing age with higher body weight or recent weight gain. The pressure is high, the CSF (spinal fluid) is normal, and imaging shows no mass. NCBI

2) Secondary intracranial hypertension (secondary “pseudotumor”). This looks similar but a cause is identified. The cause may be a medication, a medical condition, or a problem with the brain’s venous drainage such as a venous sinus thrombosis. Doctors must look for these because treatment is different when a specific cause is found. PubMed

3) IIH with papilledema (IIH-WP). This is the common presentation where the optic nerves are swollen and the eye doctor can see papilledema on exam. American Academy of Neurology

4) IIH without papilledema (IIHWOP). This is less common. The pressure is high, but the optic nerves do not look swollen. Doctors rely more on symptoms, pressure measurement, and characteristic imaging signs of raised pressure in this situation. American Academy of Neurology

5) Fulminant IIH. This is a sudden and severe form with fast vision loss over days to weeks. It needs urgent attention to protect sight. JNNP

6) Pediatric IIH. Children can get IIH. The diagnosis is similar, but pressure thresholds and patterns can differ from adults. Papilledema is less frequent in some pediatric series, and doctors take special care when measuring pressure in children. PMC

Causes and risk factors

In idiopathic IIH, there is no single proven cause. So doctors list risk factors and secondary causes that can raise pressure or mimic IIH. Not everyone with these factors will develop the condition. These help doctors look for things to treat or remove.

1. High body weight or recent weight gain. Extra body weight is strongly linked to IIH. Weight gain over a short time can also trigger symptoms. NCBI

2. Female sex and child-bearing age. The condition is most common in women in their 20s to 40s. NCBI

3. Polycystic ovary syndrome (PCOS). PCOS often occurs with weight gain and may be associated with IIH in some patients. NCBI

4. Pregnancy. Pregnancy changes fluids and hormones and can be a time when symptoms appear, so doctors watch vision closely. NCBI

5. Obstructive sleep apnea. Repeated oxygen drops at night may raise pressure swings and worsen headaches. NCBI

6. Anemia (especially iron deficiency). Low blood counts are a recognized association and are checked because treatment can help. NCBI

7. Thyroid disorders (especially low thyroid). Thyroid problems can affect fluid balance and are screened in evaluation. NCBI

8. Kidney disease or fluid retention. These conditions can shift body fluids and contribute to raised pressure. NCBI

9. Corticosteroid withdrawal. Stopping steroids suddenly can raise intracranial pressure in some people. NCBI

10. Vitamin A excess. Too much vitamin A from supplements or diet can cause intracranial hypertension. NCBI

11. Isotretinoin and related retinoids. Acne drugs related to vitamin A can raise pressure in susceptible people. NCBI

12. Tetracycline antibiotics (minocycline, doxycycline). These common antibiotics are well-known triggers of secondary intracranial hypertension. NCBI

13. Growth hormone therapy. This treatment can raise pressure in some patients and is a known association. NCBI

14. Lithium. This medicine can occasionally cause intracranial hypertension and is reviewed during medication checks. NCBI

15. Nalidixic acid and some other antimicrobials (rare today). Older reports link these drugs to raised pressure, especially in children. NCBI

16. Cyclosporine and some immunosuppressants. These can affect the brain’s pressure regulation in rare cases. NCBI

17. Hormonal contraceptives or endocrine changes (weak link). Some patients report a timing link, but evidence is mixed, so doctors assess on a case-by-case basis. NCBI

18. Cerebral venous sinus thrombosis (CVST). A clot in the brain’s venous sinuses blocks drainage and raises pressure; this is a secondary cause that must be ruled out with venous imaging. JNNP

19. Meningitis or other intracranial infections. Inflammation can block CSF flow and raise pressure; this is a secondary cause. NCBI

20. Systemic inflammatory diseases (for example, lupus or sarcoidosis). These can involve the brain’s coverings and alter CSF dynamics, leading to secondary intracranial hypertension. NCBI

Symptoms and signs

1. Headache. The headache is often daily, can be worse in the morning, and can get worse when you cough, bend, or strain. National Eye Institute

2. Transient visual obscurations (TVOs). Brief dimming or blackouts of vision lasting seconds can happen, especially when standing up or bending. American Academy of Ophthalmology

3. Blurred vision. The view may look hazy, washed out, or less sharp because of swollen optic nerves. National Eye Institute

4. Peripheral vision loss. Side vision can shrink over time if the swelling damages nerve fibers. National Eye Institute

5. Double vision. This is often from a sixth cranial nerve palsy that affects eye movement and makes two images appear. American Academy of Ophthalmology

6. Pulsatile tinnitus. People often hear a whooshing or heartbeat sound in one or both ears that matches the pulse. American Academy of Ophthalmology

7. Nausea and vomiting. These can accompany high pressure and severe headaches. National Eye Institute

8. Eye pain or pressure. The eyes may feel sore, strained, or pressured, especially with movement. American Academy of Ophthalmology

9. Neck or back pain. Muscle tension and pressure can radiate to the neck and back. NCBI

10. Photophobia. Bright light can feel uncomfortable when the optic nerve is irritated. American Academy of Ophthalmology

11. Color desaturation. Colors may look duller when the optic nerve is stressed. American Academy of Ophthalmology

12. Reduced contrast sensitivity. Fine differences in light and dark can be harder to see. PMC

13. Visual field defects on testing. Automated perimetry often shows enlarged blind spots and partial arcuate defects. PMC

14. Cognitive fog or trouble focusing. Pain, poor sleep, and pressure can reduce attention. NCBI

15. Papilledema on eye exam. The optic nerve head is swollen with blurred margins and sometimes hemorrhages, which is a hallmark sign. American Academy of Ophthalmology

Diagnostic tests

Doctors combine symptoms, eye findings, pressure measurement, and imaging. No single test stands alone. Imaging is done before lumbar puncture to rule out dangerous causes. The opening pressure number is helpful but must fit the whole picture. American Academy of OphthalmologyJNNP

A) Physical examination

1. General exam with weight and BMI. The doctor measures height and weight and calculates BMI because higher weight increases risk. They also check blood pressure, pulse, and overall health to spot other causes of headache. NCBI

2. Full neurological exam. The doctor checks strength, sensation, coordination, reflexes, and balance. The goal is to be sure there are no focal deficits that would suggest a mass or another brain problem rather than IIH. NCBI

3. Cranial nerve exam, especially eye movements. The doctor looks for a sixth nerve palsy that can cause horizontal double vision. This sign supports raised pressure when combined with other findings. American Academy of Ophthalmology

4. Pupil exam. The doctor checks for equal pupils and for a relative afferent pupillary defect (RAPD) if one optic nerve is more affected. This helps judge symmetry of optic nerve function. American Academy of Ophthalmology

5. Dilated fundus exam for papilledema. After dilating the pupils, the doctor examines the optic nerves for swelling, blurred margins, elevation, hemorrhages, or cotton wool spots. True papilledema strongly points to raised intracranial pressure. American Academy of Ophthalmology

B) Manual / bedside functional tests

6. Visual acuity (Snellen or ETDRS). Reading letters at distance and near gives a baseline for central vision. It helps track improvement or worsening over time. National Eye Institute

7. Confrontation visual fields. The doctor compares their own visual fields to the patient’s by finger counting. This quick screen can find large field losses and guides urgent care if defects are severe. American Academy of Ophthalmology

8. Color vision (Ishihara plates). Color testing is sensitive to optic nerve dysfunction and can pick up subtle changes not seen on acuity alone. American Academy of Ophthalmology

9. Cover–uncover and alternate cover tests. These simple alignment tests can reveal an inward deviation from sixth nerve palsy and confirm the cause of double vision. American Academy of Ophthalmology

10. Amsler grid at near. This grid helps patients describe waviness or missing areas in central vision, which may occur with optic nerve swelling and enlarged blind spots. PMC

C) Laboratory and pathological tests

11. Lumbar puncture with opening pressure. After brain imaging rules out a mass or venous clot, a lumbar puncture is performed. The opening pressure is measured with the patient lying on their side and relaxed. An opening pressure ≥25 cm H₂O in adults supports the diagnosis when the rest of the evaluation is normal. In children, ≥28 cm is used if obese or sedated. The CSF is then sent for analysis. American Academy of NeurologyJNNPPMC

12. CSF analysis (cells, protein, glucose). The CSF contents are usually normal in IIH. Abnormal cells, very high protein, or very low glucose suggest another disease such as infection or inflammation. American Academy of Neurology

13. Blood count and iron studies. These tests look for anemia, which can be associated with raised intracranial pressure and should be treated if present. NCBI

14. Thyroid function and pregnancy testing when appropriate. These help identify endocrine or pregnancy-related contributors so the care plan can be tailored safely. NCBI

D) Electrodiagnostic tests

These are not routine for every patient, but they can help in special situations to clarify optic nerve function.

15. Pattern-reversal visual evoked potential (VEP). This measures the electrical response of the visual pathway to a checkerboard pattern. Delays can suggest optic nerve dysfunction and help if the clinical picture is unclear. NCBI

16. Multifocal VEP. This maps responses across different parts of the visual field and can document localized dysfunction matching field loss. NCBI

17. Electroretinography (ERG / PERG). These tests measure retinal function. Normal retinal signals with abnormal VEPs support an optic nerve problem rather than a retinal disease. NCBI

E) Imaging tests

18. MRI brain with MR venography (MRV). MRI helps rule out mass lesions and shows signs of raised pressure such as an empty sella, flattening of the back of the eyeball, enlarged optic nerve sheaths, and tortuous optic nerves. MRV checks the venous sinuses for thrombosis or severe stenosis. These signs support the diagnosis when the rest of the evaluation fits IIH. PMCRadiopaedia

19. CT venography (CTV). If MRV is unavailable or contraindicated, CTV is a good alternative to image the venous sinuses and exclude a clot. JNNP

20. Optical coherence tomography (OCT) of the optic nerves and macula. OCT is a painless eye scan that measures the retinal nerve fiber layer and the ganglion cell layer. Thickening suggests swelling, and thinning over time shows damage. OCT helps track response to treatment. National Eye Institute

Non-pharmacological treatments (therapies & “other” measures)

Each item includes what it is, the purpose, and the “why it helps” mechanism in everyday language.

1. Structured weight loss program.
   What: A doctor-guided plan to steadily lose body weight (often 5–15% or more).
   Purpose: The single most effective lifestyle step to reduce pressure and protect vision.
   Why it helps: In IIH, extra body weight is tightly linked to raised brain pressure. Losing weight reduces CSF pressure and papilledema; benefits can be large and sustained. Randomized trials and follow-up studies show pressure drops as weight falls, and surgery-based weight loss is most potent for severe obesity. PubMedJAMA NetworkAmerican Academy of Neurology

2. Dietitian-led meal planning.
   What: Regular sessions with a registered dietitian.
   Purpose: Translate weight-loss goals into meals you can actually cook and stick with.
   Why: Consistent calorie deficit is easier with tailored advice, accountability, and strategies for cravings, social meals, and plateaus.

3. Low-sodium eating pattern.
   What: Emphasize fresh foods; limit salty, packaged foods.
   Purpose: Support fluid balance and blood pressure, both of which can influence symptoms.
   Why: Less sodium can reduce fluid retention, complementing medications that lower CSF production.

4. Regular physical activity you can keep doing.
   What: Brisk walking, cycling, swimming—150 minutes per week is a great starting goal.
   Purpose: Helps weight loss, mood, sleep, and headache control.
   Why: Activity increases calorie burn and improves metabolic health, which supports pressure reduction over time.

5. Treat obstructive sleep apnea (OSA).
   What: Screening for OSA and using CPAP if diagnosed.
   Purpose: Better oxygenation, fewer headaches, better daytime function.
   Why: OSA and IIH frequently coexist; treating OSA may help headache and overall pressure control indirectly via sleep and metabolic improvements.

6. Head-of-bed elevation.
   What: Raise the head of the bed 10–20 cm.
   Purpose: Reduce overnight congestion and morning headache.
   Why: Gravity helps venous drainage from the head, which may ease pressure symptoms.

7. Hydration “middle path.”
   What: Drink enough, but avoid intentional overhydration.
   Purpose: Prevent dehydration-related headaches without adding extra fluid load.
   Why: Extreme fluid swings can aggravate symptoms; balance is best.

8. Caffeine commonsense.
   What: Keep daily intake steady; avoid big spikes and late-night caffeine.
   Purpose: Prevent withdrawal headaches and improve sleep.
   Why: Irregular caffeine use can worsen headaches; stable, moderate use is gentler.

9. Migraine hygiene for headaches.
   What: Regular sleep/wake times, steady meals, screen breaks, stress tools.
   Purpose: Many IIH headaches behave like migraine; migraine habits help.
   Why: Stabilizing brain “triggers” can cut headache days even while you treat pressure.

10. Medication review and avoidance of “pressure-raising” drugs.
    What: Go through your medication/supplement list with your clinician.
    Purpose: Stop or replace medicines known to cause intracranial hypertension when possible (e.g., tetracyclines, vitamin A-derivatives/retinoids, some hormones).
    Why: These drugs can directly trigger IIH-like pressure; stopping them often improves symptoms. PMCCleveland ClinicPubMedNature

11. Vision monitoring schedule.
    What: Frequent eye exams with optic nerve photos and visual-field tests.
    Purpose: Catch vision change early—before damage becomes permanent.
    Why: Vision protection is the top priority in IIH care. PMC

12. Home symptom & weight diary.
    What: Track weight, headache days, visual spells, and medication effects.
    Purpose: See trends and share objective data with your care team.
    Why: Better data → better decisions, faster.

13. Work & study ergonomics.
    What: Lighting tweaks, larger fonts, screen breaks, anti-glare filters.
    Purpose: Ease visual strain when papilledema or transient blurring is present.
    Why: Reducing eye stress helps you function while treatment lowers pressure.

14. Stress management skills.
    What: Brief daily relaxation, breathing, mindfulness, or CBT-style skills.
    Purpose: Reduce pain amplification and improve coping.
    Why: Stress worsens perception of pain; skills can cut headache impact.

15. Weight-neutral headache supports.
    What: Choose headache strategies that don’t cause weight gain.
    Purpose: Avoid treatments that fight your weight-loss goal.
    Why: Some pain meds and preventives raise weight; your team can steer you to weight-friendly options.

16. Iron deficiency screening and correction if present.
    What: Check blood counts and iron studies when papilledema is found.
    Purpose: Treat a reversible contributor to optic nerve swelling.
    Why: Case series show papilledema can improve when iron deficiency is corrected. Nature

17. PCOS and metabolic care.
    What: Address polycystic ovary syndrome, insulin resistance, and related issues.
    Purpose: These conditions are common in IIH; managing them aids weight loss and symptom control.
    Why: Better metabolic health supports lower brain pressure over time.

18. Pregnancy planning.
    What: Preconception counseling about safer medication choices and weight goals.
    Purpose: Some IIH drugs are avoided during pregnancy; planning protects mother and baby.
    Why: Expert reviews advise avoiding acetazolamide/topiramate around conception and in pregnancy unless specialist-approved. BMJ Paediatrics+1

19. Frequent follow-up early, then taper.
    What: Closer visits while papilledema is active; lengthen intervals when stable.
    Purpose: Timely adjustments to protect vision.
    Why: Early course is the riskiest period for vision loss. PMC

20. Shared decision-making about procedures.
    What: Learn pros/cons of surgical options if vision is threatened or symptoms persist.
    Purpose: Choose the right step at the right time.
    Why: Evidence supports specific procedures in selected patients; details below. PMC

---

Drug treatments

Always use these only under your clinician’s supervision; doses below are common adult ranges, individualized for you.

1. Acetazolamide (first-line).
   Class & purpose: Carbonic anhydrase inhibitor; reduces CSF production to lower pressure and protect vision.
   Typical dose & time: Often started 250–500 mg twice daily and titrated; the IIH Treatment Trial used up to 4,000 mg/day with diet and showed better visual fields and papilledema over months. Doctors individualize targets based on effect and side effects.
   Mechanism: Slows the enzyme that helps make CSF.
   Common side effects: Tingling, fatigue, altered taste for carbonated drinks, stomach upset, kidney stones; potassium or bicarbonate shifts.
   Key evidence: Large randomized, double-blind trial showed improved visual outcomes when added to a low-sodium, weight-reduction diet. JAMA NetworkPubMedPMC

2. Topiramate (often second-line or adjunct).
   Class & purpose: Anti-seizure/migraine preventive with weak carbonic anhydrase inhibition; helps headaches, may aid weight loss, and can lower CSF production.
   Typical dose & time: Commonly 25 mg daily, titrating to 50–100 mg twice daily as tolerated; used for weeks to months.
   Mechanism: Multiple actions (inhibits carbonic anhydrase, modulates neuronal excitability).
   Common side effects: Tingling, brain “fog,” appetite loss/weight loss, mood changes; avoid in pregnancy.
   Evidence: Open-label and practice-based data suggest benefit; guidelines list it as an option (often after or with acetazolamide) especially when migraine-like headaches and weight loss goals are prominent. PubMedPractical NeurologyJNNP

3. Furosemide (adjunct).
   Class & purpose: Loop diuretic; sometimes added when acetazolamide alone is inadequate or not tolerated.
   Typical dose & time: Low doses such as 20–40 mg/day, adjusted cautiously.
   Mechanism: Diuresis and reduced sodium transport in choroid plexus may lower CSF output.
   Side effects: Dehydration, low potassium, dizziness; needs lab monitoring.
   Evidence: Limited—pediatric series and expert practice suggest add-on value; not usually used alone. PMCPractical NeurologyMedscape

4. GLP-1 receptor agonists (e.g., liraglutide, semaglutide, exenatide) for patients with obesity.
   Class & purpose: Metabolic drugs that promote weight loss; exenatide also showed direct ICP-lowering in IIH.
   Typical dose & time: Standard obesity/diabetes regimens (e.g., liraglutide up to 3 mg daily; semaglutide up to 2.4 mg weekly; exenatide dosing per product).
   Mechanism: Appetite and gut-hormone pathways; exenatide reduced ICP in a randomized placebo-controlled trial.
   Side effects: Nausea, vomiting, fullness; rare gallbladder/pancreatitis concerns.
   Evidence: RCT of exenatide showed acute and 12-week ICP reductions; observational studies show weight loss and improved headaches. Ongoing trials are expanding this area. Oxford AcademicPMCBioMed Central

5. Headache-focused preventives when ICP is controlled (for persistent migraine-like headache).
   Class & purpose: Options include CGRP monoclonal antibodies (e.g., erenumab) or other migraine preventives, chosen to avoid weight gain.
   Typical dose & time: Per migraine guidelines (monthly or quarterly for CGRP-mAbs).
   Mechanism: Reduce migraine activity; do not treat papilledema itself.
   Side effects: Vary by drug; CGRP-mAbs are generally well tolerated.
   Evidence: Case series and prospective observational data show erenumab can reduce headache days in IIH patients after papilledema resolves. Use is off-label for IIH headaches. PMCPubMed

6. Short-term analgesic strategy with MOH prevention.
   Purpose: Use acute pain medicines sparingly to avoid medication-overuse headache while long-term therapies take effect.
   Notes: Your clinician will tailor safe limits and choices.

7. Antiemetics for severe nausea.
   Purpose: Improve comfort during acute flares and allow oral meds.
   Mechanism/Notes: Symptomatic only; use short-term.

8. Potassium citrate or hydration strategies when on carbonic anhydrase inhibitors.
   Purpose: Lower kidney stone risk from acetazolamide/topiramate.
   Notes: Only if your clinician recommends it.

9. Vitamin D repletion if deficient.
   Purpose: General health, possible headache benefit if low; not a direct IIH drug.
   Notes: Dose based on blood tests and clinician advice.

10. Individualized combinations.
    Purpose: Small, thoughtful combinations (e.g., acetazolamide plus low-dose furosemide, or acetazolamide plus topiramate) may help when monotherapy is insufficient, with careful monitoring for side effects. Practical Neurology

---

Dietary “molecular” supplements

Evidence specific to IIH is limited; these mainly support headache control or correct deficiencies. Always check for interactions (especially if pregnant/trying to conceive) and avoid vitamin A supplements.

1. Magnesium citrate 400–600 mg/day. Helps quiet migraine-like brain overactivity, may reduce headache frequency; can loosen stools.

2. Riboflavin (vitamin B2) 400 mg/day. Mitochondrial support; often used for migraine prevention.

3. Coenzyme Q10 100–300 mg/day with food. Mitochondrial support; small trials show headache reductions.

4. Omega-3s (EPA+DHA) 1–3 g/day. Anti-inflammatory effects; modest benefit on some headache patterns and metabolic health.

5. Vitamin D (dose per labs, often 1,000–2,000 IU/day maintenance). Replete deficiency; broader health benefits.

6. Melatonin 3 mg at bedtime. Sleep quality and some migraine benefit; can reduce nocturnal headache sensitivity.

7. Alpha-lipoic acid 300–600 mg/day. Antioxidant/mitochondrial aid; sometimes used in neuropathic pain and headaches.

8. Iron (dose per labs) when iron deficiency is present. May lessen papilledema contribution from anemia; only when deficient. Nature

9. Folate or B-complex if deficient. Corrects nutritional gaps that can worsen fatigue and headache thresholds.

10. Electrolyte-balanced hydration (no “extreme” water loading). Practical support for steady fluid balance without triggering pressure swings.

Important: Avoid vitamin A/retinoid supplements and be cautious with any product that combines high-dose vitamin A or retinoids; these can provoke intracranial hypertension. PMC

---

Regenerative,” or “stem-cell drugs”

There are no approved immune-boosting, regenerative, or stem-cell drugs for IIH. Using such products outside a clinical trial can be unsafe, expensive, and misleading. For your safety, I can’t recommend or list unproven “stem-cell” or “immunity” drugs for IIH. The therapies with the best evidence to lower brain pressure and protect vision are weight loss, acetazolamide, selected adjunct medicines, and surgery or venous sinus stenting for specific cases—see below. PMC

---

Surgeries/procedures

1. Optic nerve sheath fenestration (ONSF).
   What: An eye-orbit surgeon makes a tiny window in the sheath around the optic nerve to let fluid escape locally.
   Why: Rapid vision protection when the optic nerves are threatened or vision is worsening despite medical therapy; it targets the eye side more than the whole brain pressure.
   Evidence: Meta-analyses and contemporary series show ONSF can preserve or improve vision with acceptable risks in experienced hands. PMCOphthalmology Advisor

2. Ventriculoperitoneal shunt (VP shunt).
   What: A small tube diverts CSF from a brain ventricle to the abdomen.
   Why: Whole-brain pressure reduction when medical therapy fails or vision continues to decline.
   Evidence: CSF diversion improves symptoms in most patients, though shunts can need revisions; standardized protocols are reducing early failure. The LancetJournal of Neurosurgery

3. Lumboperitoneal shunt (LP shunt).
   What: A tube diverts CSF from the lower spine to the abdomen.
   Why: Another diversion option when VP shunt isn’t ideal.
   Evidence: LP and VP shunts have broadly comparable failure and complication rates; choice depends on anatomy and surgeon experience. Frontiers

4. Dural venous sinus stenting.
   What: A stent opens a narrowed brain venous sinus seen on imaging with a pressure gradient.
   Why: For selected patients with venous outflow narrowing and pressure gradients who remain symptomatic or visually threatened despite medication/weight loss.
   Evidence: Systematic reviews and meta-analyses suggest stenting can help symptoms and pressure, but long-term durability and selection criteria continue to be studied. PubMed+1

5. Metabolic (bariatric) surgery in patients with significant obesity.
   What: Procedures such as gastric bypass or sleeve gastrectomy to produce major, durable weight loss.
   Why: Powerful pressure reduction and high rates of IIH remission in appropriate patients. In a randomized trial, surgery outperformed a community weight program for lowering ICP with benefits sustained at 2 years. Early data suggest bypass may reduce ICP faster than sleeve even before large weight changes. PubMedJAMA NetworkPMC

---

Prevention pointers

1. Reach and maintain a healthy weight; even 5–10% loss helps pressure. PubMed

2. Review all medications and cosmetics/skin products; avoid tetracyclines and retinoids where alternatives exist. PMC

3. Don’t take vitamin A supplements unless your clinician specifically prescribes them (and then only at safe doses). Drugs.com

4. Treat sleep apnea if present; use CPAP as prescribed.

5. Keep salt intake moderate and steady.

6. Use weight-neutral strategies for chronic headaches; avoid daily painkiller overuse.

7. Plan pregnancies; discuss safer medication options in advance. BMJ Paediatrics

8. Keep regular eye checkups when you’ve had IIH before or have symptoms. PMC

9. Correct iron deficiency if it’s found. Nature

10. Build consistent sleep, movement, and stress-reduction routines to lower headache load.

---

When to see a doctor urgently

• New or rapidly worsening headache with blurred vision, double vision, transient vision blackouts, or a new whooshing/pulsing sound in the ear.

• Visible swelling of optic discs (papilledema) on any eye check.

• Headache plus exposure to tetracyclines, vitamin A derivatives (including some acne therapies), or growth hormone—especially within weeks of starting them. Stop the offending drug and seek care. Cleveland Clinic

• Pregnancy or planning pregnancy while on IIH medicines—get specialist advice early. BMJ Paediatrics

---

What to eat” and “what to avoid

Eat more of:

1. Colorful vegetables and fruit to fill half your plate (nutrient-dense, low-calorie).

2. Lean proteins (fish, skinless poultry, tofu, pulses) for fullness.

3. High-fiber whole grains (oats, brown rice, quinoa) to control appetite.

4. Healthy fats from nuts, seeds, and olive oil in modest amounts.

5. Water and unsweetened beverages; keep intake steady through the day.

Limit/avoid:

1. Sugary drinks and ultra-processed snacks—easy calories that fight weight goals.
2.  Very salty foods (instant noodles, chips, processed meats); they can increase fluid retention.
3. Alcohol, which can disrupt sleep and headaches.
4. Vitamin A/retinoid supplements and high-dose “beauty” supplements unless prescribed. PMC
5.  Big late-night meals and irregular caffeine patterns (they worsen sleep and headaches).

---

Frequently asked questions

1. Is pseudotumor cerebri a brain tumor?
   No. The name is historical. There’s no tumor—just high pressure in normal brain fluid spaces.

2. What causes it?
   In many adults, excess body weight and hormonal/metabolic factors play major roles. Certain medications (tetracyclines, vitamin A derivatives, growth hormone, lithium) can cause a similar picture and must be reviewed. Nature

3. Can IIH make me blind?
   It can threaten vision if untreated. That’s why frequent eye exams and timely treatment matter. PMC

4. What’s the best first treatment?
   Weight loss plus acetazolamide is the best-supported starting plan for many patients with mild visual loss. JAMA Network

5. How long will I take acetazolamide?
   Often months; your team tapers once vision and papilledema stabilize. Dose and duration are individualized based on effect and side effects. PMC

6. What if I can’t tolerate acetazolamide?
   Options include topiramate (especially if migraine-like headache and weight goals are present) and carefully chosen add-ons. Practical Neurology

7. Do GLP-1 weight-loss medicines help IIH?
   Yes for weight loss, and exenatide also directly lowered ICP in an RCT. These medicines are increasingly used in appropriate patients with obesity. Oxford Academic

8. Will a lumbar puncture cure me?
   A lumbar puncture can temporarily lower pressure and help diagnose IIH, but the effect usually fades. Lasting control comes from the treatments above. PMC

9. When is surgery considered?
   If vision is worsening despite medications/weight loss or if symptoms remain severe, procedures like ONSF, CSF shunting, or venous sinus stenting may be offered after specialist evaluation. PMCThe LancetPubMed

10. Which shunt is better: VP or LP?
    Both help. Choice depends on your anatomy and surgical team; failure/complication rates can be similar. Frontiers

11. Does bariatric surgery really help brain pressure?
    Yes. In a randomized clinical trial, bariatric surgery lowered ICP more than a community weight program and sustained the benefit for at least two years. PubMed

12. Can I use migraine injections (CGRP antibodies)?
    Sometimes, for persistent migraine-like headaches after papilledema is controlled; they treat headache, not the eye swelling. Evidence is from case series/prospective cohorts. PMC

13. Is pregnancy safe with IIH?
    Many women do well with careful planning. Some drugs (acetazolamide, topiramate) are avoided around conception and in pregnancy unless a specialist advises otherwise. Weight optimization beforehand helps. BMJ Paediatrics

14. Which products should I stop right away?
    Never stop prescription medicines without advice, but alert your clinician immediately if you are on tetracyclines, vitamin A/retinoids, or growth hormone—these are recognized triggers. Cleveland Clinic

15. Will IIH come back?
    It can. Keeping weight steady, following up on vision, and avoiding trigger medicines reduce the risk. PMC

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: August 23, 2025.